Secondary analysis of AFACT trial and MARK-AF registry data: of 449 patients having thoracoscopic ablation for advanced AF, 39.2% had early recurrence, which was associated with late recurrence (HR 1.52 at 0–30 days, 2.01 at 31–90 days vs none).
Secondary analysisn = 449
Dong et al. Clinical, histologic, and molecular associations of early and late recurrence after thoracoscopic ablation for atrial fibrillation